Idogen AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was SEK 0.414 million compared to SEK 13.92 million a year ago. Net loss was SEK 47.75 million compared to SEK 38.85 million a year ago.

Basic loss per share from continuing operations was SEK 0.74 compared to SEK 2.02 a year ago. Diluted loss per share from continuing operations was SEK 0.74 compared to SEK 2.02 a year ago.